Skip to main content
JETEMA Co.,Ltd. logo

JETEMA Co.,Ltd. — Investor Relations & Filings

Ticker · 216080 ISIN · KR7216080002 KO Manufacturing
Open in API
Filings indexed 397 across all filing types
Latest filing 2022-01-24 Earnings Release
Country KR South Korea
Listing KO 216080

About JETEMA Co.,Ltd.

http://www.jetema.com/

JETEMA Co., Ltd. is a research-driven biopharmaceutical company specializing in the development and manufacturing of innovative medicines and medical devices for the aesthetic medicine market. The company's core product portfolio includes botulinum toxins, hyaluronic acid-based dermal fillers, and lifting threads. With a strong focus on research and development, JETEMA aims to provide advanced solutions for anti-aging and aesthetic enhancement. The company's name is derived from the Latin word 'Zetéma', meaning 'research', reflecting its commitment to scientific innovation in creating products for a healthy and beautiful life.

Recent filings

Filing Released Lang Actions
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (Jetema) announcing a significant change in revenue or profit structure (30% or more). This type of disclosure is a standard preliminary financial announcement required by the Korea Exchange (KRX) when there is a material change in financial performance before the final audit is completed. It provides key financial highlights (revenue, operating profit, net income) and the reasons for the change. Since it is an initial announcement of financial results rather than a full annual report or a transcript, it falls under the Earnings Release category. FY 2021
2022-01-24 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act (Article 147). This document details the shareholding status, changes in ownership, and related contracts (such as stock collateral agreements) of major shareholders and their special related parties. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2022-01-21 Korean
전환가액의조정(제8회차)
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing regarding the adjustment of the conversion price for convertible bonds (8th series) issued by the company 'Jetema'. It details the change in conversion price, the number of convertible shares, the calculation methodology based on market price fluctuations, and the effective date. This falls under capital structure changes related to debt-to-equity instruments, which is best classified as a Capital/Financing Update.
2022-01-07 Korean
단일판매ㆍ공급계약해지(자율공시)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) regarding the termination of a single sales and supply contract. It provides specific details about the contract value, the counterparty, the reason for termination (COVID-19/market conditions), and the date of termination. Since this is a specific regulatory disclosure regarding a material business event (contract termination) that does not fit into categories like M&A, financial reports, or shareholder communications, it is classified as a general regulatory filing.
2021-12-29 Korean
수시공시의무관련사항(공정공시)(히알루론산 필러 ODM 계약 체결)
Regulatory Filings Classification · 100% confidence The document is a 'Fair Disclosure' (공정공시) filing from the company Jetema regarding a specific business contract (ODM supply agreement for hyaluronic acid fillers). It details the counterparty, contract value, duration, and regional scope. Since this is a regulatory announcement of a material business event that does not fit into specific categories like M&A (TAR) or Share Issues (SHA), it falls under the general regulatory filing category.
2021-12-21 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date and shareholder register closure for an upcoming Annual General Meeting (AGM). It does not contain the full AGM materials or proxy statements, but rather serves as a formal notice of the procedural steps for the meeting. Given the nature of the announcement as a regulatory disclosure of corporate action, it fits best under the RNS category.
2021-12-16 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.